H.R. 5366: Alzheimer’s Breakthrough Sunshine Act

To amend the Internal Revenue Code of 1986 to exclude from gross income for seven years amounts earned from the sale of drugs that demonstrate breakthrough therapies for treating Alzheimer's disease.

The bill’s titles are written by its sponsor.

What you can do



May 26, 2016


Referred to Committee on May 26, 2016

This bill was assigned to a congressional committee on May 26, 2016, which will consider it before possibly sending it on to the House or Senate as a whole.


Patrick Murphy

Representative for Florida's 18th congressional district



Read Text »
Last Updated: May 26, 2016
Length: 3 pages


1% chance of being enacted according to PredictGov (details)


May 26, 2016

This is the first step in the legislative process.

Reported by Committee

Passed House

Passed Senate

Signed by the President

H.R. 5366 is a bill in the United States Congress.

A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.

How to cite this information.

We recommend the following MLA-formatted citation when using the information you see here in academic work:

“H.R. 5366 — 114th Congress: Alzheimer’s Breakthrough Sunshine Act.” www.GovTrack.us. 2016. October 27, 2016 <https://www.govtrack.us/congress/bills/114/hr5366>

Where is this information from?

GovTrack automatically collects legislative information from a variety of governmental and non-governmental sources. This page is sourced primarily from Congress.gov, the official portal of the United States Congress. Congress.gov is generally updated one day after events occur, and so legislative activity shown here may be one day behind. Data via the congress project.